Luminsa, Lian Jay L.

HRN: 22-34-04  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2022
CEFTRIAXONE 1G (VIAL)
12/13/2022
12/19/2022
IV
2g
OD
Seizure Disorder Prob Sec To TB Meningitis
Waiting Final Action 
12/19/2022
MUPIROCIN 2%, 15G (TUBE)
12/19/2022
12/24/2022
TOPICAL
Apply On Affected Area
8 Hrs
Bed Sore
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: